相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1
Loic Lionnard et al.
CELL DEATH AND DIFFERENTIATION (2019)
TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling
Wanhu Fan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Increased expression of tripartite motif (TRIM) like 2 promotes tumoral growth in human oral cancer
Fumihiko Hayashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis
Linmei Wang et al.
CANCER BIOLOGY & THERAPY (2019)
TRIM11 cooperates with HSF1 to suppress the anti-tumor effect of proteotoxic stress drugs
Liang Chen et al.
CELL CYCLE (2019)
Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway
Yi-Jiong Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Upregulation of pyruvate kinase M2 expression by fatty acid synthase contributes to gemcitabine resistance in pancreatic cancer
Shenghua Tian et al.
ONCOLOGY LETTERS (2018)
Tripartite motif-containing protein 3 plays a role of tumor inhibitor in cervical cancer
Yu Song et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway
Liyin Li et al.
CELL BIOLOGY INTERNATIONAL (2018)
Tripartite motif 31 promotes resistance to anoikis of hepatocarcinoma cells through regulation of p53-AMPK axis
Pengbo Guo et al.
EXPERIMENTAL CELL RESEARCH (2018)
TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer
Ken-ichi Takayama et al.
ONCOGENE (2018)
TRIM14 promotes chemoresistance in gliomas by activating Wnt/beta-catenin signaling via stabilizing Dvl2
Zhanyao Tan et al.
ONCOGENE (2018)
Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway
Chao Yu et al.
THERANOSTICS (2018)
Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells
Ksenia S. Anufrieva et al.
GENOME MEDICINE (2018)
TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-kappa B pathway
Ting-Ting Zhao et al.
JOURNAL OF CANCER (2018)
Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer
Lorenzo Stramucci et al.
CANCERS (2018)
An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling
Geyan Wu et al.
CANCER RESEARCH (2018)
TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway
Yunxiao Liu et al.
MOLECULAR CARCINOGENESIS (2018)
DNA repair pathways and cisplatin resistance: an intimate relationship
Clarissa Ribeiro Reily Rocha et al.
CLINICS (2018)
TRIM32 overexpression improves chemoresistance through regulation of mitochondrial function in non-small-cell lung cancers
Yaming Du et al.
ONCOTARGETS AND THERAPY (2018)
Aberrant RNA Splicing in Cancer and Drug Resistance
Bi-Dar Wang et al.
CANCERS (2018)
The Role of Tripartite Motif Family Proteins in TGF-β Signaling Pathway and Cancer
Ho-Jae Lee
JOURNAL OF CANCER PREVENTION (2018)
Controlled drug delivery vehicles for cancer treatment and their performance
Sudipta Senapati et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer
Ravi Salgia et al.
TRENDS IN CANCER (2018)
TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells
Jeffrey Q. Nguyen et al.
CANCER BIOLOGY & THERAPY (2017)
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
Giovanni Luca Beretta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
Robert Cornelison et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours
Francesca Mastropasqua et al.
MOLECULAR CANCER (2017)
Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity
Aman Sharma
NANOMEDICINE (2017)
miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer
Xijun Wang et al.
ONCOLOGY REPORTS (2017)
Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity
Ramin Rezaee et al.
PHARMACOLOGICAL RESEARCH (2017)
TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis
Shigetsugu Hatakeyama
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Expression of tripartite motif-containing protein 28 in primary breast carcinoma predicts metastasis and is involved in the stemness, chemoresistance, and tumor growth
Surekha Damineni et al.
TUMOR BIOLOGY (2017)
miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8
Yao Liu et al.
OncoTargets and Therapy (2017)
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma
Deguan Lv et al.
NATURE COMMUNICATIONS (2017)
Tumor Evolution as a Therapeutic Target
Nabil Amirouchene-Angelozzi et al.
CANCER DISCOVERY (2017)
The molecular mechanisms of chemoresistance in cancers
Hua-Chuan Zheng
ONCOTARGET (2017)
TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role
Mariano Francesco Caratozzolo et al.
GENES (2017)
Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
T. Avril et al.
ONCOGENESIS (2017)
Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53
Jinjin Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The impact of the IGF-1 system of cancer cells on radiation response - An in vitro study
Senthiladipan Venkatachalam et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2017)
Curcumin enhances the radiosensitivity of renal cancer cells by suppressing NF-κB signaling pathway
Gang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
The complexity of TRIM28 contribution to cancer
Patrycja Czerwinska et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Molecular chess? Hallmarks of anti-cancer drug resistance!
Ian A. Cree et al.
BMC CANCER (2017)
Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development
Mei-Yu Piao et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth
Huai-Peng Lin et al.
CANCER RESEARCH (2016)
Molecular mechanisms for tumour resistance to chemotherapy
Shu-Ting Pan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)
TRIMming p53's anticancer activity
S. Elabd et al.
ONCOGENE (2016)
Chemical probes and inhibitors of bromodomains outside the BET family
Moses Moustakim et al.
MEDCHEMCOMM (2016)
Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53
Shan Xu et al.
ONCOLOGY LETTERS (2016)
Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma
Brian A. Boone et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival
Lucia Micale et al.
BMC CANCER (2015)
ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8 Ubiquitin Ligase
Huibin Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Therapy-induced tumour secretomes promote resistance and tumour progression
Anna C. Obenauf et al.
NATURE (2015)
TRIM25 has a dual function in the p53/Mdm2 circuit
P. Zhang et al.
ONCOGENE (2015)
Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers
Qianshan Ding et al.
TUMOR BIOLOGY (2015)
TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance
Zhi-Feng Miao et al.
VIRCHOWS ARCHIV (2015)
TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome
Yu Chen et al.
ONCOTARGET (2015)
Identification of TRIML2, a Novel p53 Target, that Enhances p53 SUMOylation and Regulates the Transactivation of Proapoptotic Genes
Che-Pei Kung et al.
MOLECULAR CANCER RESEARCH (2015)
TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway
L-H Zhang et al.
ONCOGENE (2015)
Combined MTOR and autophagy inhibition Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma
Reshma Rangwala et al.
AUTOPHAGY (2014)
The Four Faces of Autophagy: Implications for Cancer Therapy
David A. Gewirtz
CANCER RESEARCH (2014)
E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis
Ju Liu et al.
CELL DEATH AND DIFFERENTIATION (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
TRIM59 Is Up-regulated in Gastric Tumors, Promoting Ubiquitination and Degradation of p53
Zhicheng Zhou et al.
GASTROENTEROLOGY (2014)
TRIM24 Is a p53-Induced E3-Ubiquitin Ligase That Undergoes ATM-Mediated Phosphorylation and Autodegradation during DNA Damage
Abhinav K. Jain et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Nucleotide Biosynthetic Enzyme GMP Synthase Is a TRIM21-Controlled Relay of p53 Stabilization
B. Ashok Reddy et al.
MOLECULAR CELL (2014)
TRIM3, a tumor suppressor linked to regulation of p21Waf1/Cip1
Y. Liu et al.
ONCOGENE (2014)
TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma
Mariano Francesco Caratozzolo et al.
ONCOTARGET (2014)
Reduced intracellular drug accumulation in drug-resistant leukemia cells is not only solely due to MDR-mediated efflux but also to decreased
Angela Oliveira Pisco et al.
FRONTIERS IN ONCOLOGY (2014)
Phytochemicals As Chemosensitizers: From Molecular Mechanism to Clinical Significance
Balachandran S. Vinod et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
DNA damage repair and tolerance: a role in chemotherapeutic drug resistance
M. R. Salehan et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2013)
TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity
Moshe E. Gatt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas
C-H Fan et al.
CELL DEATH & DISEASE (2013)
Mechanisms and insights into drug resistance in cancer
Hiba Zahreddine et al.
FRONTIERS IN PHARMACOLOGY (2013)
Targeting nuclear factor-kappa B to overcome resistance to chemotherapy
P. Godwin et al.
FRONTIERS IN ONCOLOGY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization
Min Shen et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Cellular senescence and cancer chemotherapy resistance
Ryan R. Gordon et al.
DRUG RESISTANCE UPDATES (2012)
TRIM39 regulates cell cycle progression and DNA damage responses via stabilizing p21
Lei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ubiquitylation of p53 by the APC/C inhibitor Trim39
Liguo Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
TRIM29 negatively regulates p53 via inhibition of Tip60
Takuya Sho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Mechanism of Cell Adaptation When and How Do Cancer Cells Develop Chemoresistance?
Valentina Fodale et al.
CANCER JOURNAL (2011)
TRIM40 promotes neddylation of IKKγ and is downregulated in gastrointestinal cancers
Keita Noguchi et al.
CARCINOGENESIS (2011)
Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of MKT and MDM2
Hae Mi Joo et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β-triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination
Qi Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Reactivation of p53: from peptides to small molecules
Christopher J. Brown et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Erik Kupperman et al.
CANCER RESEARCH (2010)
TRIM8 modulates STAT3 activity through negative regulation of PIAS3
Fumihiko Okumura et al.
JOURNAL OF CELL SCIENCE (2010)
Curcumin Suppresses Constitutive Activation of STAT-3 by Up-Regulating Protein Inhibitor of Activated STAT-3 (PIAS-3) in Ovarian and Endometrial Cancer Cells
Manush Saydmohammed et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Mechanisms of tumor resistance to EGFR-targeted therapies
Elizabeth A. Hopper-Borge et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Discovery of new pyridoacridine alkaloids from Lissoclinum cf. badium that inhibit the ubiquitin ligase activity of Hdm2 and stabilize p53
Jason A. Clement et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Identification of inhibitors for MDM2 ubiquitin ligase activity from natural product extracts by a novel high-throughput electrochemiluminescent screen
Christy A. Sasiela et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
TRIM family proteins and their emerging roles in innate immunity
Keiko Ozato et al.
NATURE REVIEWS IMMUNOLOGY (2008)
TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases
G Meroni et al.
BIOESSAYS (2005)
Trim family proteins:: Retroviral restriction and antiviral defence
S Nisole et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Overcoming resistance of cancer cells to apoptosis
P Hersey et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Ubiquitin: not just for proteasomes anymore
RC Aguilar et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
TRIM8/GERP RING finger protein interacts with SOCS-1
E Toniato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Gene expression - Emerging roles of ubiquitin in transcription regulation
RC Conaway et al.
SCIENCE (2002)
The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
MH Glickman et al.
PHYSIOLOGICAL REVIEWS (2002)
Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot
D Negorev et al.
ONCOGENE (2001)
The tripartite motif family identifies cell compartments
A Reymond et al.
EMBO JOURNAL (2001)
Structure and function of a human TAFII250 double bromodomain module
RH Jacobson et al.
SCIENCE (2000)
RING finger proteins: Mediators of ubiquitin ligase activity
CAP Joazeiro et al.
CELL (2000)
分享论文
